SCHUYLER ELLIS: Open Payments
NPI 1538709738 · PORTLAND, OR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$491 in 12 payments from 5 companies in 2025. Trend: 2023 $528 · 2024 $215 · 2025 $491
Food & beverage: $491
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 4 | $282 |
| ABBVIE INC. | 2 | $73 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $68 |
| Lundbeck LLC | 2 | $46 |
| Neurocrine BioSciences, Inc. | 1 | $22 |
Products named: COBENFY, TRINTELLIX, REXULTI, VRAYLAR, INGREZZA.
Industry payments across OR — which companies pay providers there.
